Evidence map›Paper›PMID 20592026›Full record

ArticleThe Journal of biological chemistry2010

Antigenic Variation among Bordetella: Bordetella bronchiseptica strain MO149 expresses a novel o chain that is poorly immunogenic.

Evgeny Vinogradov, Jerry D King, Ashutosh K Pathak, Eric T Harvill, Andrew Preston

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Genetic diversity ofFrontiers in microbiology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Age and Periodontal Health - Immunological View.Current oral health reports · 2018
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Evgeny VinogradovInstitute for Biological Sciences, National Research Council, Ottawa, Ontario K1A 0R6, Canada.
Jerry D KingDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario N1G 2W1, Canada.
Ashutosh K PathakDepartment of Veterinary and Biomedical Science, Pennsylvania State University, University Park, Pennsylvania 16802, United Kingdom.
Eric T HarvillDepartment of Veterinary and Biomedical Science, Pennsylvania State University, University Park, Pennsylvania 16802, United Kingdom.
Andrew PrestonDepartment of Clinical Veterinary Science, University of Bristol, Langford, North Somerset BS40 5DU, United Kingdom. Electronic address: a.preston@bristol.ac.uk.
Pennsylvania State University · USInstitute for Biological Sciences · CAUniversity of Bristol · GBUniversity of Guelph · CA

Funding

Evolution of the Bordetellae from Commensals to PathogensR01GM083113 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI HARVILL, ERIC T · 2008 to 2011
$2.1M
Comparative Immunobiology of the bordetellaeR01AI053075 · NIAID · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI HARVILL, ERIC T. · 2003 to 2007
$1.4M
NIAID NIH HHS R01 AI053075NIGMS NIH HHS GM083113NIGMS NIH HHS R01 GM083113
6 · The paper itself

Abstract

The O chain polysaccharide (O PS) of Bordetella bronchiseptica and Bordetella parapertussis lipopolysaccharide is a homopolymer of 2,3-diacetamido-2,3-dideoxygalacturonic acid (GalNAc3NAcA) in which some of the sugars are present as uronamides. The terminal residue contains several unusual modifications. To date, two types of modification have been characterized, and a survey of numerous strains demonstrated that each contained one of these two modification types. Host antibody responses against the O PS are directed against the terminal residue modifications, and there is little cross-reactivity between the two types. This suggests that Bordetella O PS modifications represent a means of antigenic variation. Here we report the characterization of the O PS of B. bronchiseptica strain MO149. It consists of a novel two-sugar repeating unit and a novel terminal residue modification, with the structure Me-4-alpha-L-GalNAc3NAcA-(4-beta-D-GlcNAc3NAcA-4-alpha-L-GalNAc3NAcA-)(5-6)-, which we propose be defined as the B. bronchiseptica O3 PS. We show that the O3 PS is very poorly immunogenic and that the MO149 strain contains a novel wbm (O PS biosynthesis) locus. Thus, there is greater diversity among Bordetella O PSs than previously recognized, which is likely to be a result of selection pressure from host immunity. We also determine experimentally, for the first time, the absolute configuration of the diacetimido-uronic acid sugars in Bordetella O PS.

Indexed as

AnimalsAntigens, BacterialBordetella bronchisepticaCarbohydrate ConformationGenetic LociLipopolysaccharidesMiceAntigens, BacterialLipopolysaccharides

Identifiers

PMID20592026
PMCPMC2930686
OpenAlexW1963649327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.